[Enteral non-Hodgkin lymphoma in young age--difficult diagnosis]. / Limfom non-Hodgkinian forma enterala la tânar, caz subdiagnosticat.

Lately, we have been confronted with an increased number of malignant tumors of the large bowel, appearing at younger patients. Among all histopathologic forms of malignant colonic tumors treated in our Clinic, lymphoma is the fifth as frequency of apparition, respectively the fourth at patients less than 40 years old. We present the case of a 22-years-old patient, having colonic polyposis and multicentric non-Hodgkin lymphoma of the terminal ileum and ascending colon. This pathologic association represented for us an uncommon situation. The rest of malignant colonic tumors developed on patients with rectocolonic polyposis were adenocarcinoma.

[Complications in morbid obesity treatment--pylorus obstruction caused by a deflated intragastric balloon]. / Complicatii în tratamentul obezitatii--obstructie pilorica prin balon intragastric.

An aggressive array of new treatments and improvements of existing approaches for addressing morbid obesity were developed during the last two decades in response to the recognition that a new pandemic affects humanity, i.e. obesity. Initially used as a temporizing solution for other specific interventions used for obesity treatment, the endoscopic placement of an intragastric balloons has currently became in certain cases a complete therapeutic solution. Multiple studies emphasize the efficiency of this new therapeutic method, in some cases resulting in a 45 kg weight loss at the end of the monitoring period. The intragastric balloon, after endoscopic placement can be kept into position for an average period of 4-6 months. After this period, balloon extraction is recommended because of the complications that can occur with prolonged intragastric placement. This paper presents a case of pyloric obstruction by an intragastric balloon kept for 14 months. In this case, the initial approach was endoscopic, but the surgical approach offered the definitive therapeutic solution.